Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy and Safety of 3% Minoxidil Lotion for Chest Hair Enhancement

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02283645
Recruitment Status : Unknown
Verified November 2014 by Chuchai TANGLERTSAMPAN, MD, Mae Fah Luang University Hospital.
Recruitment status was:  Not yet recruiting
First Posted : November 5, 2014
Last Update Posted : December 2, 2014
Sponsor:
Information provided by (Responsible Party):
Chuchai TANGLERTSAMPAN, MD, Mae Fah Luang University Hospital

Brief Summary:
The purpose of this study is to determine efficacy and safety of 3% minoxidil lotion for chest hair enhancement.

Condition or disease Intervention/treatment Phase
Chest Hair Enhancement Drug: 3 % minoxidil lotion Drug: Placebo Phase 4

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 64 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Efficacy and Safety of 3% Minoxidil Lotion for Chest Hair Enhancement : A Randomized, Double-blind, Placebo-controlled Study
Study Start Date : January 2015
Estimated Primary Completion Date : August 2015
Estimated Study Completion Date : August 2015

Resource links provided by the National Library of Medicine

Drug Information available for: Minoxidil

Arm Intervention/treatment
Experimental: Minoxidil
3% Minoxidil lotion is applied twice daily to the chest.
Drug: 3 % minoxidil lotion
Placebo Comparator: Placebo
Placebo lotion is applied twice daily to the chest.
Drug: Placebo



Primary Outcome Measures :
  1. The change of global photographic assessment after 20 weeks from baseline [ Time Frame: baseline and 20 weeks ]

Secondary Outcome Measures :
  1. The change in number of hairs after 20 weeks from baseline [ Time Frame: baseline and 20 weeks ]

Other Outcome Measures:
  1. The change of hair diameter after 20 weeks from baseline [ Time Frame: baseline and 20 weeks ]
  2. Number of participants with adverse events [ Time Frame: baseline and 20 weeks ]
  3. Patient satisfaction by self-assessment questionnaires [ Time Frame: baseline and 20 weeks ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 45 Years   (Adult)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • healthy male

Exclusion Criteria:

  • serious underlying diseases
  • history of chest/ hair treatment before 6 months
  • history of surgery or trauma on chest area.
  • history of minoxidil allergy

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02283645


Contacts
Layout table for location contacts
Contact: Chuchai Tanglertsampan, MD drchuchait@yahoo.com
Contact: Sittichai Ingprasert, MD sittichai113@hotmail.com

Sponsors and Collaborators
Mae Fah Luang University Hospital